SEC Form D · Amendment · filed December 16, 2022
A2 Biotherapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (33)
David S. Lucas · Agoura Hills, CAExecThomas S. Leung · Agoura Hills, CAExecJakob S. Loven · Agoura Hills, CADirectorScott Foraker · Agoura Hills, CAExec · DirectorHelen S. Kim · Agoura Hills, CADirectorSusan L. Kelley · Agoura Hills, CADirectorMadhavan Balachandran · Agoura Hills, CADirectorWilliam S. Go · Agoura Hills, CAExecSrini Akkaraju · Agoura Hills, CADirectorAlexander Kamb · Agoura Hills, CAExec · DirectorDavid Goeddel · Agoura Hills, CADirectorJason Zhang · Stamford, CTDirectorOscar Vasquez · Corte Madera, CAExecScott T. Harris · Dallas, TXExecJonathan Behr · London, United KingdomExec · DirectorGriffin Davis · Tysons, VAExecRussell T. Shattan · Dallas, TXExec · DirectorAnthony Avila · Corte Madera, CADirectorRalph Achacoso · Stamford, CTDirectorKate Bingham · London, United KingdomDirectorHouman Ashrafian · London, United KingdomDirectorCroatan Investment Management LLC · VIRGINIA BEACH, VADirectorJames Gibson · Excelsior, MNExec · DirectorJohn Menzies · Austin, TXDirectorKevin Puil · Austin, TXDirectorDaniel Gay · BOSTON, MADirectorDaniel Armbrust · Santa Clara, CADirectorJohn Provine · Santa Clara, CADirectorArun Gollakota · New York, NYExecSteve Kreidler · Golden, CODirectorSherman Ragland · Upper Marlboro, MDExecJw Roth · Colorado Springs, COExecChristopher T. Russo · Lancaster, PAExec · Director Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗